Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 17, 2017 (10 years ago)

Kalbitor (ecallantide)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: Glass

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Kalbitor (ecallantide), 10mg/mL, packaged in 3 vials per Carton, Rx Only, Dynax Corp., Burlington, MA. NDC47783-101-01

Recalling firm
Shire
NDC code
47783-101-01
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0625-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Shire

All 2017 recalls
Class III · Low risk

Pentasa (mesalamine)

Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules

Terminated Particulate / foreign matter Shire PLC NDC 54092-189-81 D-0432-2017

Other particulate / foreign matter recalls from 2017

All particulate / foreign matter recalls
Class III · Low risk

Auryxia (ferric citrate)

Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle.

Terminated Particulate / foreign matter Keryx Biopharmaceuticals, Inc. NDC 59922-631-01 D-0133-2018